In this interview, we spoke with Gloria Gerber, MD, a hematologist and assistant professor of medicine at Johns Hopkins University, about the evolution of treatment for paroxysmal nocturnal ...
Diagnosed at a young age with a rare and potentially life-threatening disease, one man learned the power of taking control. When South Carolinian Roger was diagnosed with paroxysmal nocturnal ...
Findings from a post hoc analysis of 3 clinical trials support the switching to or initiation of pegcetacoplan to manage fatigue for patients with paroxysmal nocturnal hemoglobinuria (PNH) that is ...
Dr De Castro explores considerations surrounding cost in treatment of PNH. Carlos M. De Castro, MD: The cost utilization study looked at health care costs associated with PNH [paroxysmal nocturnal ...
Because paroxysmal nocturnal hemoglobinuria (PNH) is a rare condition, many people may struggle to find the support they need. One patient advocate offers ways to cope. Paroxysmal nocturnal ...
"We need longer follow-up with the newer complement inhibitors to be sure that they’re safe long-term and that there won’t be excessive intravascular breakthrough hemolysis/thrombosis. Some of these ...
SÃO PAULO--(BUSINESS WIRE)--Pint Pharma and OrphanDC announced on July 25th that ANVISA, the National Health Surveillance Agency, approved, on July 25th, 2023, the drug EMPAVELI® (pegcetacoplan, ...
Patients who are taking complement inhibitors may still experience breakthrough hemolysis associated with respiratory viral infections. Patients with PNH should be closely monitored for signs of ...
(RTTNews) - Roche Holding AG (RHHBY) announced today that the EMA's Committee for Medicinal Products for Human Use or CHMP recommended PiaSky as a monthly subcutaneous treatment for paroxysmal ...
(RTTNews) - Omeros Corp. (OMER), Friday announced that it has initiated clinical trial site activation for its Phase 3 program evaluating zaltenibart or OMS906 in paroxysmal nocturnal hemoglobinuria ...
EXTON, PA, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Spherix Global Insights has released its first annual chart audit study in hematology, PatientChart Dynamix™ : Paroxysmal Nocturnal Hemoglobinuria (PNH) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results